Privia Health Group, Inc. (PRVA)

Privia Health Group Stock Forecast

Stock Price Forecast

The 14 analysts that cover Privia Health Group stock have a consensus rating of "Strong Buy" and an average price target of $30.07, which forecasts a 32.58% increase in the stock price over the next year. The lowest target is $23 and the highest is $36.

Price Target: $30.07 (+32.58%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$23	$30.07	$30	$36
Change	+1.41%	+32.58%	+32.28%	+58.73%

Analyst Ratings

The average analyst rating for Privia Health Group stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jun '25	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25
Strong Buy	4	4	4	4	4	4
Buy	9	9	9	9	9	9
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	14	14	14	14	14	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Lisa Gill JP Morgan	JP Morgan	Buy Maintains $32 → $33	Buy	Maintains	$32 → $33	+45.50%	Nov 13, 2025
Sean Dodge BMO Capital	BMO Capital	Buy Initiates $30	Buy	Initiates	$30	+32.28%	Nov 13, 2025
Richard Close Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $32 → $34	Strong Buy	Maintains	$32 → $34	+49.91%	Nov 12, 2025
Andrew Mok Barclays	Barclays	Hold Maintains $22 → $23	Hold	Maintains	$22 → $23	+1.41%	Nov 10, 2025
Jailendra Singh Truist Securities	Truist Securities	Strong Buy Reiterates $30 → $31	Strong Buy	Reiterates	$30 → $31	+36.68%	Nov 10, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

3.42B

Increased by 96.90%

from 1.74B

Revenue Next Year

3.45B

Increased by 1.02%

from 3.42B

EPS This Year

0.17

Increased by 53.99%

from 0.11

EPS Next Year

0.33

Increased by 92.82%

from 0.17

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	817.08M	966.22M	1.36B	1.66B	1.74B	3.42B	3.45B
Revenue Growth	3.91%	18.25%	40.41%	22.19%	4.75%	96.90%	1.02%
EPS	0.33	-1.83	-0.08	0.19	0.11	0.17	0.33
EPS Growth	278.92%	-	-	-	-42.11%	53.99%	92.82%
Forward PE	-	-	-	-	-	133.89	69.44
No. Analysts	-	-	-	-	-	21	21

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	3.6B	4.0B
Avg	3.4B	3.5B
Low	3.2B	2.1B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	106.5%	17.9%
Avg	96.9%	1.0%
Low	86.9%	-37.7%

EPS Forecast

EPS	2025	2026	2027
High	0.24	0.44
Avg	0.17	0.33
Low	0.10	0.24

EPS Growth

EPS Growth	2025	2026	2027
High	119.5%	160.3%
Avg	54.0%	92.8%
Low	-10.9%	38.9%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.